CGRP Inhibitors Market Booms at 12% CAGR, Soaring from US$300 Million to US$663 Million by 2030, Persistence Market Research New York, Jan. 17, 2024 (GLOBE NEWSWIRE) -- CGRP inhibitors comprise a pharmaceutical category tailored to alleviate and manage migraine headaches. Their core objective is grounded in their ability...

Birmingham Chiropractor Offers Treatments for Drug-Free Headache Relief BIRMINGHAM, Ala., Sept. 28, 2014 (GLOBE NEWSWIRE) -- A Birmingham chiropractor is making use of natural healing methods to relieve neck pain, headaches, and migraines for area residents. According to...